Cardiopulmonary bypass in cardiac surgery;Kardiopulmonaler bypass in der herzchirurgie

Anaesthesist

Volumn 61, Issue 10, 2012, Pages 846-856

  Baehner, T ^a   Boehm, O ^a   Probst, C ^a   Poetzsch, B ^a   Hoeft, A ^a   Baumgarten, G ^a   Knuefermann, P ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cardioplegia; Extracorporeal circulation; Heart lung machine; Off pump coronary artery bypass; Systemic inflammatory response syndrome

Indexed keywords

ARTICLE; CARDIOPULMONARY BYPASS; COGNITIVE DEFECT; HEART FAILURE; HEART SURGERY; LUNG DISEASE; MECHANICAL STRESS; NEUROLOGIC DISEASE; SURGICAL INJURY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORAX SURGERY;

CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; EXTRACORPOREAL CIRCULATION; HEART-LUNG MACHINE; HISTORY, 20TH CENTURY; HUMANS; POSTOPERATIVE COMPLICATIONS; THORACIC SURGERY;

EID: 84871102712     PISSN: 00032417     EISSN: 1432055X     Source Type: Journal    
DOI: 10.1007/s00101-012-2050-0     Document Type: Article

References (122)

1. Ahmed I, House CM, Nelson WB (2009) Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB). J Cardiothorac Surg 4:24
2. Alghamdi AA, Latter DA (2006) Pulsatile versus nonpulsatile cardiopulmonary bypass flow: an evidence-based approach. J Card Surg 21:347-354
3. Ali MS, Harmer M, Vaughan R (2000) Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaesth 85:287-298
4. Allan CK, Newburger JW, Mcgrath E et al (2010) The relationship between inflammatory activation and clinical outcome after infant cardiopulmonary bypass. Anesth Analg 111:1244-1251
5. Andersen LW, Baek L, Degn H et al (1987) Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 93:115-119
6. Angelini GD, Taylor FC, Reeves BC et al (2002) Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials. Lancet 359:1194-1199
7. Apostolakis EE, Koletsis EN, Baikoussis NG et al (2010) Strategies to prevent intraoperative lung injury during cardiopulmonary bypass. J Cardiothorac Surg 5:1
8. Ascione R, Lloyd CT, Underwood MJ et al (2000) Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 69:1198-1204
9. Asimakopoulos G (2001) Systemic inflammation and cardiac surgery: an update. Perfusion 16:353-360
10. Asimakopoulos G, Smith PL, Ratnatunga CP et al (1999) Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 68:1107-1115
11. Bartels C, Gerdes A, Babin-Ebell J et al (2002) Cardiopulmonary bypass: evidence or experience based? J Thorac Cardiovasc Surg 124:20-27
12. Bauer TL, Arepally G, Konkle BA et al (1997) Prevalence of heparin-Associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 95:1242-1246
13. Biancari F, Lahtinen J, Lepojarvi S et al (2003) Preoperative C-reactive protein and outcome after coronary artery bypass surgery. Ann Thorac Surg 76:2007-2012
14. Biancari F, Rimpilainen R (2009) Meta-Analysis of randomised trials comparing the effectiveness of miniaturised versus conventional cardiopulmonary bypass in adult cardiac surgery. Heart 95:964-969
15. Bilgin YM, Brand A (2008) Transfusion-related immunomodulation: a second hit in an inflammatory cascade? Vox Sang 95:261-271
16. Boeken U, Litmathe J, Feindt P et al (2005) Neurological complications after cardiac surgery: risk factors and correlation to the surgical procedure. Thorac Cardiovasc Surg 53:33-36
17. Boldt J, Brenner T, Lehmann A et al (2003) Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg 75:906-912
18. Bretschneider HJ (1980) Myocardial protection. Thorac Cardiovasc Surg 28:295-302
19. Breuer T, Martin K, Wilhelm M et al (2009) The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery. Eur J Cardiothorac Surg 35:167-171
20. Brooker RF, Brown WR, Moody DM et al (1998) Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg 65:1651-1655
21. Cha J, Wang Z, Ao L et al (2008) Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. Ann Thorac Surg 85:1678-1685
22. Chai PJ, Williamson JA, Lodge AJ et al (1999) Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass. Ann Thorac Surg 67:731-735
23. Chaney MA, Nikolov MP, Blakeman BP et al (2000) Protective ventilation attenuates postoperative pulmonary dysfunction in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 14:514-518
24. Conlon PJ, Stafford-Smith M, White WD et al (1999) Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14:1158-1162
25. Das DK, Engelman RM, Liu X et al (1992) Oxygen-derived free radicals and hemolysis during open heart surgery. Mol Cell Biochem 111:77-86
26. Diegeler A, Doll N, Rauch T et al (2000) Humoral immune response during coronary artery bypass grafting: a comparison of limited approach, off-pump-Technique, and conventional cardiopulmonary bypass. Circulation 102:III95-100
27. Edmunds LH Jr, Colman RW (2006) Thrombin during cardiopulmonary bypass. Ann Thorac Surg 82:2315-2322
28. Elmistekawy EM, Rubens FD (2011) Deep hypothermic circulatory arrest: alternative strategies for cerebral perfusion. A review article. Perfusion 26(Suppl 1):27-34
29. Fellahi JL, Gue X, Richomme X et al (2003) Short-And long-Term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 99:270-274
30. Fergusson DA, Hebert PC, Mazer CD et al (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358:2319-2331
31. Fontes ML, Amar D, Kulak A et al (2009) Increased preoperative white blood cell count predicts postoperative atrial fibrillation after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 23:484-487
32. Gravlee RFD GP, Stammers AH, Ungerleider RM (2007) Cardiopulmonary bypass: principles and practice. Lippincott Williams & Wilkins, Philadelphia
33. Gagnon J, Laporta D, Beique F et al (2010) Clinical relevance of ventilation during cardiopulmonary bypass in the prevention of postoperative lung dysfunction. Perfusion 25:205-210
34. Gasz B, Lenard L, Racz B et al (2006) Effect of cardiopulmonary bypass on cytokine network and myocardial cytokine production. Clin Cardiol 29:311-315
35. Gibbon JH Jr (1954) Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 37:171-185
36. Gravlee GP, Davis RF, Stammers AH, Ungerleider RM (2007) Cardiopulmonary bypass: principles and practice. Lippincott Williams & Wilkins, Philadelphia
37. Grogan K, Stearns J, Hogue CW (2008) Brain protection in cardiac surgery. Anesthesiol Clin 26:521-538
38. Groom RC, Quinn RD, Lennon P et al (2010) Microemboli from cardiopulmonary bypass are associated with a serum marker of brain injury. J Extra Corpor Technol 42:40-44
39. Haase M, Bellomo R, Haase-Fielitz A (2010) Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-Associated acute kidney injury. J Am Coll Cardiol 55:2024-2033
40. Hashemzadeh K, Dehdilani M (2009) Postoperative cardiac troponin I is an independent predictor of in-hospital death after coronary artery bypass grafting. J Cardiovasc Surg (Torino) 50:403-409
41. Hedman A, Larsson PT, Alam M et al (2007) CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events? Int J Cardiol 120:108-114
42. Hoedemaekers C, Van Deuren M, Sprong T et al (2010) The complement system is activated in a biphasic pattern after coronary artery bypass grafting. Ann Thorac Surg 89:710-716
43. Hogue CW Jr, Palin CA, Arrowsmith JE (2006) Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesth Analg 103:21-37
44. Johnson D, Hurst T, Thomson D et al (1996) Respiratory function after cardiac surgery. J Cardiothorac Vasc Anesth 10:571-577
45. Just SS, Muller T, Hartrumpf M et al (2006) First experience with closed circuit/centrifugal pump extracorporeal circulation: cellular trauma, coagulatory, and inflammatory response. Interact Cardiovasc Thorac Surg 5:646-648
46. Karkouti K, Beattie WS, Wijeysundera DN et al (2005) Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg 129:391-400
47. Karkouti K, Wijeysundera DN, Yau TM et al (2004) The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 44:1453-1462
48. Karkouti K, Wijeysundera DN, Yau TM et al (2009) Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 119:495-502
49. Kats S, Schonberger JP, Brands R et al (2011) Endotoxin release in cardiac surgery with cardiopulmonary bypass: pathophysiology and possible therapeutic strategies. An update. Eur J Cardiothorac Surg 39:451-458
50. Khalil PN, Ismail M, Kalmar P et al (2004) Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass. Thromb Haemost 92:568-574
51. Klos A, Tenner AJ, Johswich KO et al (2009) The role of the anaphylatoxins in health and disease. Mol Immunol 46:2753-2766
52. Kobayashi J, Tashiro T, Ochi M et al (2005) Early outcome of a randomized comparison of off-pump and on-pump multiple arterial coronary revascularization. Circulation 112:I338-343
53. Kozek-Langenecker SA (2008) Direct thrombin inhibitors: pharmacology and application in cardiovascular anesthesia. Anaesthesist 57:597-606
54. Laffey JG, Boylan JF, Cheng DC (2002) The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 97:215-252
55. Lampa M, Ramsay J (1999) Anesthetic implications of new surgical approaches to myocardial revascularization. Curr Opin Anaesthesiol 12:3-8
56. Landoni G, Bove T, Crivellari M et al (2007) Acute renal failure after isolated CABG surgery: six years of experience. Minerva Anestesiol 73: 559-565
57. Leary MC, Caplan LR (2007) Technology insight: brain MRI and cardiac surgery-detection of postoperative brain ischemia. Nat Clin Pract Cardiovasc Med 4:379-388
58. Levy JH, Tanaka KA (2003) Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75:715-720
59. Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250-1256
60. Li SY, Chen JY, Yang WC et al (2011) Acute kidney injury network classification predicts in-hospital and long-Term mortality in patients undergoing elective coronary artery bypass grafting surgery. Eur J Cardiothorac Surg 39:323-328
61. Maharaj C, Laffey JG (2004) New strategies to control the inflammatory response in cardiac surgery. Curr Opin Anaesthesiol 17:35-48
62. Mangano DT, Tudor IC, Dietzel C (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354:353-365
63. Mangoush O, Purkayastha S, Haj-Yahia S et al (2007) Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. Eur J Cardiothorac Surg 31:1058-1069
64. Manji RA, Grocott HP, Leake J et al (2012) Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anaesth 59:6-13
65. Marcheix B, Carrier M, Martel C et al (2008) Effect of pericardial blood processing on postoperative inflammation and the complement pathways. Ann Thorac Surg 85:530-535
66. Martel N, Lee J, Wells PS (2005) Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-Analysis. Blood 106:2710-2715
67. Masuda M, Morita S, Tomita H et al (2002) Off-pump CABG attenuates myocardial enzyme leakage but not postoperative brain natriuretic peptide secretion. Ann Thorac Cardiovasc Surg 8:139-144
68. Mathew JP, Grocott HP, Phillips-Bute B et al (2003) Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. Stroke 34:508-513
69. McKhann GM, Grega MA, Borowicz LM Jr et al (2006) Stroke and encephalopathy after cardiac surgery: an update. Stroke 37:562-571
70. McKinlay KH, Schinderle DB, Swaminathan M et al (2004) Predictors of inotrope use during separation from cardiopulmonary bypass. J Cardiothorac Vasc Anesth 18:404-408
71. Milot J, Perron J, Lacasse Y et al (2001) Incidence and predictors of ARDS after cardiac surgery. Chest 119:884-888
72. Misfeld M, Potger K, Ross DE et al (2010) Anaortic" off-pump coronary artery bypass grafting significantly reduces neurological complications compared to off-pump and conventional on-pump surgery with aortic manipulation. Thorac Cardiovasc Surg 58:408-414
73. Mulholland JW, Shelton JC, Luo XY (2005) Blood flow and damage by the roller pumps during cardiopulmonary bypass. J Fluids Struct 20:129-140
74. Muller H, Hugel W, Reifschneider HJ et al (1989) Lysosomal enzyme activity influenced by various types of respiration during extracorporeal circulation. Thorac Cardiovasc Surg 37:65-71
75. Murphy GJ, Angelini GD (2004) Side effects of cardiopulmonary bypass: what is the reality? J Card Surg 19:481-488
76. Murphy GS, Hessel EA 2nd, Groom RC (2009) Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg 108:1394-1417
77. Murphy GS, Marymont JH (2007) Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery. J Cardiothorac Vasc Anesth 21:113-126
78. Nakayama Y, Sakata R, Ura M et al (2003) Long-Term results of coronary artery bypass grafting in patients with renal insufficiency. Ann Thorac Surg 75:496-500
79. Neuhof C, Wendling J, Dapper F et al (2001) Endotoxemia and cytokine generation in cardiac surgery in relation to flow mode and duration of cardiopulmonary bypass. Shock 16(Suppl 1):39-43
80. Newman MF, Kirchner JL, Phillips-Bute B et al (2001) Longitudinal assessment of neurocognitive function after coronary-Artery bypass surgery. N Engl J Med 344:395-402
81. Nieman G, Searles B, Carney D et al (1999) Systemic inflammation induced by cardiopulmonary bypass: a review of pathogenesis and treatment. J Extra Corpor Technol 31:202-210
82. Nilsson L, Kulander L, Nystrom SO et al (1990) Endotoxins in cardiopulmonary bypass. J Thorac Cardiovasc Surg 100:777-780
83. Nishiyama K, Horiguchi M, Shizuta S et al (2009) Temporal pattern of strokes after on-pump and off-pump coronary artery bypass graft surgery. Ann Thorac Surg 87:1839-1844
84. Paparella D, Yau TM, Young E (2002) Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21:232-244
85. Parolari A, Alamanni F, Naliato M et al (2000) Adult cardiac surgery outcomes: role of the pump type. Eur J Cardiothorac Surg 18:575-582
86. Patel KD, Cuvelier SL, Wiehler S (2002) Selectins: critical mediators of leukocyte recruitment. Semin Immunol 14:73-81
87. Pavord ID, Birring SS, Berry M et al (2006) Multiple inflammatory hits and the pathogenesis of severe airway disease. Eur Respir J 27:884-888
88. Penttila HJ, Lepojarvi MV, Kiviluoma KT et al (2001) Myocardial preservation during coronary surgery with and without cardiopulmonary bypass. Ann Thorac Surg 71:565-571
89. Potzsch B, Klovekorn WP, Madlener K (2000) Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia. N Engl J Med 343:515
90. Pouplard C, May MA, Regina S et al (2005) Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Br J Haematol 128:837-841
91. Provenchere S, Plantefeve G, Hufnagel G et al (2003) Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: incidence, risk factors, and effect on clinical outcome. Anesth Analg 96:1258-1264
92. Puehler T, Haneya A, Philipp A et al (2011) Minimized extracorporeal circulation system in coronary artery bypass surgery: a 10-year single-center experience with 2243 patients. Eur J Cardiothorac Surg 39:459-464
93. Puskas JD, Williams WH, Duke PG et al (2003) Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:797-808
94. Raja SG, Berg GA (2007) Impact of off-pump coronary artery bypass surgery on systemic inflammation: current best available evidence. J Card Surg 22:445-455
95. Reis Miranda D, Gommers D, Struijs A et al (2005) Ventilation according to the open lung concept attenuates pulmonary inflammatory response in cardiac surgery. Eur J Cardiothorac Surg 28:889-895
96. Riess FC (2005) Anticoagulation management and cardiac surgery in patients with heparin-induced thrombocytopenia. Semin Thorac Cardiovasc Surg 17:85-96
97. Rinder CS, Rinder HM, Smith MJ et al (1999) Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation. J Thorac Cardiovasc Surg 118:460-466
98. Robert AM, Kramer RS, Dacey LJ et al (2010) Cardiac surgery-Associated acute kidney injury: a comparison of two consensus criteria. Ann Thorac Surg 90:1939-1943
99. Rosner MH, Portilla D, Okusa MD (2008) Cardiac surgery as a cause of acute kidney injury: pathogenesis and potential therapies. J Intensive Care Med 23:3-18
100. Saadia R, Schein M (1999) Multiple organ failure. How valid is the two hit" model? J Accid Emerg Med 16:163-166
101. Schlensak C, Doenst T, Preusser S et al (2002) Cardiopulmonary bypass reduction of bronchial blood flow: a potential mechanism for lung injury in a neonatal pig model. J Thorac Cardiovasc Surg 123:1199-1205
102. Schneeweiss S, Seeger JD, Landon J et al (2008) Aprotinin during coronary-Artery bypass grafting and risk of death. N Engl J Med 358:771-783
103. Shaw AD, Stafford-Smith M, White WD et al (2008) The effect of aprotinin on outcome after coronary-Artery bypass grafting. N Engl J Med 358:784-793
104. Sheridan AM, Bonventre JV (2000) Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens 9:427-434
105. Shroyer AL, Grover FL, Hattler B et al (2009) On-pump versus off-pump coronary-Artery bypass surgery. N Engl J Med 361:1827-1837
106. Sreeram GM, Grocott HP, White WD et al (2004) Transcranial Doppler emboli count predicts rise in creatinine after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 18:548-551
107. Stroobant N, Van Nooten G, De Bacquer D et al (2008) Neuropsychological functioning 3-5 years after coronary artery bypass grafting: does the pump make a difference? Eur J Cardiothorac Surg 34:396-401
108. Stroobant N, Van Nooten G, Van Belleghem Y et al (2005) Relation between neurocognitive impairment, embolic load, and cerebrovascular reactivity following on-And off-pump coronary artery bypass grafting. Chest 127:1967-1976
109. Suen WS, Mok CK, Chiu SW et al (1998) Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery. Angiology 49:789-800
110. Suh JS, Aster RH, Visentin GP (1998) Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: platelet factor 4. Blood 91:916-922
111. Tabuchi N, De Haan J, Boonstra PW et al (1993) Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg 106:828-833
112. Tempe DK, Hasija S (2012) Are tranexamic acid and epsilon-Aminocaproic acid adequate substitutes for aprotinin? Ann Card Anaesth 15:4-5
113. Ti LK, Goh BL, Wong PS et al (2008) Comparison of mini-cardiopulmonary bypass system with air-purge device to conventional bypass system. Ann Thorac Surg 85:994-1000
114. Toumpoulis IK, Anagnostopoulos CE, Balaram SK et al (2006) Assessment of independent predictors for long-Term mortality between women and men after coronary artery bypass grafting: are women different from men? J Thorac Cardiovasc Surg 131:343-351
115. Ueyama K, Nishimura K, Nishina T et al (2004) PMEA coating of pump circuit and oxygenator may attenuate the early systemic inflammatory response in cardiopulmonary bypass surgery. ASAIO J 50:369-372
116. Valen G, Paulsson G, Vaage J (2001) Induction of inflammatory mediators during reperfusion of the human heart. Ann Thorac Surg 71:226-232
117. Van Dijk D, Nierich AP, Jansen EW et al (2001) Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation 104:1761-1766
118. Wan S, Desmet JM, Barvais L et al (1996) Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 112:806-811
119. Warkentin TE, Greinacher A, Koster A et al (2008) Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:340-380
120. Warren OJ, Smith AJ, Alexiou C et al (2009) The inflammatory response to cardiopulmonary bypass: part 1-mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 23:223-231
121. Wiesenack C, Liebold A, Philipp A et al (2004) Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs 28:1082-1088
122. Wright G (2001) Haemolysis during cardiopulmonary bypass: update. Perfusion 16:345-351